Related to Schepens Eye Institute Receives Unrestricted Grant to Progress Retinal Stem Cell Collaboration with ReNeuron

• CIRM Commits $25M to Overcome Immune Rejection of Stem Cell Therapies
  
• California Institute for Regenerative Medicine Bankrolls 12 Grants with $243M
  
• NIH Gives $4.66M Award for Stimulation of Neuron Regeneration in the Retina
  
• First Patient Receives ReNeuron’s Neural Stem Cell Therapy
  
• BMGF Provides $3.61M for Collaborative Project to Develop Onchocerciasis Therapy
  
• StemCells Snags Swissmedic OK to Start Neural Stem Cell Trial in Spinal Cord Injury
  
• Cephalon Shells Out $350M to Commercialize Mesoblast Stem Cell Therapies
  
• Case Western Reserve University Wins $10M Award to Study Retinal Diseases
  
• Angel Biotech to Conduct Development and Manufacturing for ReNeuron’s Stem Cell Program
  
• Cellerix Secures €4.95M for Phase III Study of Allogeneic Adult Stem Cell Therapy
  
• First Clinical Trial of Autologous Cardiac Stem Cells Shows Positive Results
  
• TAP, UCL Receive Additional Funding to Take Biomimetic Cornea into Human Safety Study
  
• University of Miami’s Interdisciplinary Stem Cell Institute Awarded $10M
  
• Osiris Wins Race to Market a Stem Cell Product with Canadian Go-Ahead
  
• CHOC Children’s Research Institute Wins $5.5M Grant for Stem Cell Project
  
• Cytori Adopts Sistemic's Platform for Stem Cells Trial
  
• Stem Cells Save Teeth
  
• Dainippon Sumitomo Invests $16M in RIKEN Company
  
• URMC Gets $15M to Study Homspera as a Radiation-Induced Injury Countermeasure
  
• ReNeuron Licenses Schepens IP for Human Retinal Precursor Cell Therapies